{
  "main_header": {
    "sid": 10039717,
    "name": "Studio LSD",
    "stock_name": "Studio LSD",
    "full_name": "Studio LSD Ltd",
    "name_url": "stocks-analysis/studio-lsd",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "14.30",
    "chg": -0.05,
    "chgp": "-0.35%",
    "dir": -1,
    "prev_price": "14.35",
    "mcapval": "74.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "STUDIOLSD",
    "ind_name": "Media & Entertainment",
    "ind_code": 83,
    "indexname": "",
    "isin": "INE17VO01028",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": 38000,
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/studio-lsd-10039717-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Studio LSD overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-studio-lsd-overvalued-or-undervalued-3713780",
        "imagepath": "",
        "date": "2025-11-19 08:13:11",
        "description": "As of 18 November 2025, the valuation grade for Studio LSD has moved from does not qualify to very attractive, indicating a significant improvement in its investment appeal. The company is currently assessed as undervalued, particularly when considering its strong financial ratios. The PE ratio stands at 7.25, while the EV to EBITDA ratio is 5.16, both of which are substantially lower than those of its peers. The ROCE is an impressive 68.71%, and the ROE is 42.74%, showcasing the company's efficiency in generating returns.\n\nIn comparison to its peers, Studio LSD's valuation metrics are strikingly favorable. For instance, Prime Focus is categorized as expensive with a PE ratio of 86.17, and City Pulse Multi is deemed very expensive with a PE ratio of 1982.93. This stark contrast highlights Studio LSD's potential for growth and value. While the stock has underperformed relative to the Sensex over the past wee..."
      },
      {
        "title": "How has been the historical performance of Studio LSD?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-studio-lsd-3704463",
        "imagepath": "",
        "date": "2025-11-15 00:40:30",
        "description": "Answer:\nThe historical performance of Studio LSD shows significant growth in various financial metrics from March 2023 to March 2024.\n\nBreakdown:\nIn the fiscal year ending March 2024, Studio LSD reported net sales of 102.48 Cr, a substantial increase from 46.68 Cr in March 2023. Total operating income mirrored this growth, reaching 102.48 Cr compared to 46.68 Cr the previous year. The company's total expenditure also rose to 87.65 Cr from 42.94 Cr, driven by higher raw material costs of 66.46 Cr, up from 33.01 Cr. Operating profit (PBDIT) saw a notable increase to 14.85 Cr from 3.78 Cr, resulting in an operating profit margin of 14.47%, up from 8.01%. Profit before tax improved to 14.66 Cr from 3.64 Cr, and profit after tax rose to 10.90 Cr from 2.79 Cr, reflecting a PAT margin increase to 10.64% from 5.98%. The company's reserves grew significantly to 15.86 Cr from 4.95 Cr, and earnings per share surged to..."
      }
    ],
    "total": 2,
    "sid": "10039717",
    "stock_news_url": "https://www.marketsmojo.com/news/studio-lsd-10039717"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Studio LSD overvalued or undervalued?

2025-11-19 08:13:11

As of 18 November 2025, the valuation grade for Studio LSD has moved from does not qualify to very attractive, indicating a significant improvement in its investment appeal. The company is currently assessed as undervalued, particularly when considering its strong financial ratios. The PE ratio stands at 7.25, while the EV to EBITDA ratio is 5.16, both of which are substantially lower than those of its peers. The ROCE is an impressive 68.71%, and the ROE is 42.74%, showcasing the company's efficiency in generating returns. In comparison to its peers, Studio LSD's valuation metrics are strikingly favorable. For instance, Prime Focus is categorized as expensive with a PE ratio of 86.17, and City Pulse Multi is deemed very expensive with a PE ratio of 1982.93. This stark contrast highlights Studio LSD's potential for growth and value. While the stock has underperformed relative to the Sensex over the past wee...

Read More

How has been the historical performance of Studio LSD?

2025-11-15 00:40:30

Answer: The historical performance of Studio LSD shows significant growth in various financial metrics from March 2023 to March 2024. Breakdown: In the fiscal year ending March 2024, Studio LSD reported net sales of 102.48 Cr, a substantial increase from 46.68 Cr in March 2023. Total operating income mirrored this growth, reaching 102.48 Cr compared to 46.68 Cr the previous year. The company's total expenditure also rose to 87.65 Cr from 42.94 Cr, driven by higher raw material costs of 66.46 Cr, up from 33.01 Cr. Operating profit (PBDIT) saw a notable increase to 14.85 Cr from 3.78 Cr, resulting in an operating profit margin of 14.47%, up from 8.01%. Profit before tax improved to 14.66 Cr from 3.64 Cr, and profit after tax rose to 10.90 Cr from 2.79 Cr, reflecting a PAT margin increase to 10.64% from 5.98%. The company's reserves grew significantly to 15.86 Cr from 4.95 Cr, and earnings per share surged to...

Read More

View All News